Funder
National Natural Science Foundation of China
Guangdong Provincial Department of Science and Technology
National Key Clinical Specialty Discipline Construction Program of China
Guangdong Medical University
Technology Bureau of Zhanjiang Municipality
Subject
Pharmacology,General Medicine
Reference78 articles.
1. Cisplatin in cancer treatment;Romani;Biochem. Pharm.,2022
2. Istradefylline protects from cisplatin-induced nephrotoxicity and peripheral neuropathy while preserving cisplatin antitumor effects;Dewaeles;J. Clin. Invest.,2022
3. Potential therapeutic targets for cisplatin-induced kidney injury: lessons from other models of AKI and fibrosis;Sears;J. Am. Soc. Nephrol.,2021
4. Prevention of cisplatin-induced acute kidney injury: a systematic review and meta-analysis;Hamroun;Drugs,2019
5. Dioscin protects against cisplatin-induced acute kidney injury by reducing ferroptosis and apoptosis through activating Nrf2/HO-1 signaling;Wang;Antioxid. (Basel),2022